BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36169181)

  • 21. Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network.
    Huang H; Yan L; Zhong J; Hong L; Zhang N; Luo X
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):275-286. PubMed ID: 35196944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gomisin N enhances TRAIL-induced apoptosis via reactive oxygen species-mediated up-regulation of death receptors 4 and 5.
    Inoue H; Waiwut P; Saiki I; Shimada Y; Sakurai H
    Int J Oncol; 2012 Apr; 40(4):1058-65. PubMed ID: 22179661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetrandrine Reverses Paclitaxel Resistance in Human Ovarian Cancer via Inducing Apoptosis, Cell Cycle Arrest Through β-Catenin Pathway.
    Jiang L; Hou R
    Onco Targets Ther; 2020; 13():3631-3639. PubMed ID: 32431514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability.
    Young Park J; Wook Yun J; Whan Choi Y; Ung Bae J; Won Seo K; Jin Lee S; Youn Park S; Whan Hong K; Kim CD
    Hypertens Res; 2012 Sep; 35(9):928-34. PubMed ID: 22534517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells.
    Yuan H; Sun B; Gao F; Lan M
    Pharm Biol; 2016 Nov; 54(11):2629-2635. PubMed ID: 27159496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer
    O'Donnell J; Zhao Z; Buckingham L; Hao T; Suo H; Zhang X; Fan Y; John C; Deng B; Shen X; Sun W; Secord AA; Zhou C; Bae-Jump VL
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FKA-A NPs enhances PTX-A NPs efficacy to suppress ovarian cancer via regulating Skp2/YAP pathway.
    Li J; Wang R; Liu Y; Wu Y; Han L; Zheng L; Bao Z
    Fundam Clin Pharmacol; 2023 Feb; 37(1):125-136. PubMed ID: 36028983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue inhibitor of metalloproteinase-1 protects MCF-7 breast cancer cells from paclitaxel-induced apoptosis by decreasing the stability of cyclin B1.
    Wang T; Lv JH; Zhang XF; Li CJ; Han X; Sun YJ
    Int J Cancer; 2010 Jan; 126(2):362-70. PubMed ID: 19609944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
    Wang Y; Dong L; Li J; Luo M; Shang B
    Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 15-Hydroxy-8(17),13(E)-labdadiene-19-carboxylic acid (HLCA) inhibits proliferation and induces cell cycle arrest and apoptosis in ovarian cancer cells.
    Bakhtiari H; Gheysarzadeh A; Ghanadian M; Aghaei M
    Life Sci; 2021 Feb; 267():118981. PubMed ID: 33385409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.
    Karthikeyan S; Hoti SL; Nazeer Y; Hegde HV
    Oncotarget; 2016 Jul; 7(27):42353-42373. PubMed ID: 27304668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gomisin A ameliorates metastatic melanoma by inhibiting AMPK and ERK/JNK-mediated cell survival and metastatic phenotypes.
    Han YH; Mun JG; Jeon HD; Park J; Kee JY; Hong SH
    Phytomedicine; 2020 Mar; 68():153147. PubMed ID: 32028184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.
    Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
    Int J Nanomedicine; 2019; 14():6269-6285. PubMed ID: 31496685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo.
    Wang C; Wang R; Zhou K; Wang S; Wang J; Shi H; Dou Y; Yang D; Chang L; Shi X; Liu Y; Xu X; Zhang X; Ke Y; Liu H
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):971-982. PubMed ID: 27620208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice.
    Alalawy AI; Sakran M; Alzuaibr FM; Alotaibi MA; El-Hefnawy ME; Hazazi AY; El-Gendy SM; Aidy EA; Effat H; Ismail DF; Hessien M
    Sci Rep; 2023 Dec; 13(1):22782. PubMed ID: 38129495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers.
    Yang H; Shu Z; Jiang Y; Mao W; Pang L; Redwood A; Jeter-Jones SL; Jennings NB; Ornelas A; Zhou J; Rodriguez-Aguayo C; Bartholomeusz G; Iles LR; Zacharias NM; Millward SW; Lopez-Berestein G; Le XF; Ahmed AA; Piwnica-Worms H; Sood AK; Bast RC; Lu Z
    Clin Cancer Res; 2019 Sep; 25(18):5702-5716. PubMed ID: 31391192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zerumbone-induced reactive oxygen species-mediated oxidative stress re-sensitizes breast cancer cells to paclitaxel.
    Li J; Wang L; Sun Y; Wang Z; Qian Y; Duraisamy V; Antary TMA
    Biotechnol Appl Biochem; 2023 Feb; 70(1):28-37. PubMed ID: 35240000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive effect of gomisin J from Schisandra chinensis on angiotensin II-induced hypertension via an increased nitric oxide bioavailability.
    Ye BH; Lee SJ; Choi YW; Park SY; Kim CD
    Hypertens Res; 2015 Mar; 38(3):169-77. PubMed ID: 25427681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geldanamycin, an inhibitor of Hsp90, increases paclitaxel-mediated toxicity in ovarian cancer cells through sustained activation of the p38/H2AX axis.
    Mo Q; Zhang Y; Jin X; Gao Y; Wu Y; Hao X; Gao Q; Chen P
    Tumour Biol; 2016 Nov; 37(11):14745-14755. PubMed ID: 27629142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic p21 is responsible for paclitaxel resistance in ovarian cancer A2780 cells.
    Xia X; Ji T; Liu R; Weng Y; Fang Y; Wang Z; Xu H
    Eur J Gynaecol Oncol; 2015; 36(6):662-6. PubMed ID: 26775347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.